These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 1453564

  • 1. [Clinical application of 18F-FDG-PET in patients with brain death].
    Momose T, Nishikawa J, Watanabe T, Ohtake T, Sasaki Y, Sasaki M, Mii K.
    Kaku Igaku; 1992 Sep; 29(9):1139-42. PubMed ID: 1453564
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
    Oriuchi N, Tomiyoshi K, Inoue T, Ahmad K, Sarwar M, Tokunaga M, Suzuki H, Watanabe N, Hirano T, Horikoshi S, Shibasaki T, Tamura M, Endo K.
    J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method.
    Schmidt K, Lucignani G, Moresco RM, Rizzo G, Gilardi MC, Messa C, Colombo F, Fazio F, Sokoloff L.
    J Cereb Blood Flow Metab; 1992 Sep; 12(5):823-34. PubMed ID: 1506447
    [Abstract] [Full Text] [Related]

  • 7. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors.
    Weber W, Bartenstein P, Gross MW, Kinzel D, Daschner H, Feldmann HJ, Reidel G, Ziegler SI, Lumenta C, Molls M, Schwaiger M.
    J Nucl Med; 1997 May; 38(5):802-8. PubMed ID: 9170450
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Evaluation of the cases of benign disease with high accumulation on the examination of 18F-fluorodeoxyglucose PET].
    Okazumi S, Enomoto K, Fukunaga T, Kikuchi T, Asano T, Isono K, Arimizu N, Imazeki K, Ito Y, Yamamoto H.
    Kaku Igaku; 1993 Dec; 30(12):1439-43. PubMed ID: 8107315
    [Abstract] [Full Text] [Related]

  • 17. Decreased cerebral glucose metabolism in patients with brain tumors: an effect of corticosteroids.
    Fulham MJ, Brunetti A, Aloj L, Raman R, Dwyer AJ, Di Chiro G.
    J Neurosurg; 1995 Oct; 83(4):657-64. PubMed ID: 7674016
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Parametric images of myocardial metabolic rate of glucose generated from dynamic cardiac PET and 2-[18F]fluoro-2-deoxy-d-glucose studies.
    Choi Y, Hawkins RA, Huang SC, Gambhir SS, Brunken RC, Phelps ME, Schelbert HR.
    J Nucl Med; 1991 Apr; 32(4):733-8. PubMed ID: 2013815
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.